Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY ISSUE OF JANUARY 14, 2007 FBO #1875
SOLICITATION NOTICE

66 -- Roche Diagnostics Corporation Genome Sequencer FLX upgrade.

Notice Date
1/12/2007
 
Notice Type
Solicitation Notice
 
NAICS
334516 — Analytical Laboratory Instrument Manufacturing
 
Contracting Office
US Army Medical Research Acquisition Activity, ATTN: MCMR-AAA, 820 Chandler Street, Frederick, MD 21702-5014
 
ZIP Code
21702-5014
 
Solicitation Number
W81XWH07T075
 
Response Due
1/26/2007
 
Archive Date
3/27/2007
 
Small Business Set-Aside
N/A
 
Description
The U.S. Army Medical Research Acquisition Activity (USAMRAA) intends to negotiate a sole source contract with Roche Diagnostics Corporation. The procurement will provide the National Biodefense Analysis and Countermeasures Center (NBFAC) with missi on critical equipment upgrade. The NBFAC is requesting a Roche Diagnostics Corporation genome sequencer FLX upgrade. This instrument is sued for the purpose of whole geneome sequnecing asnd the upgrade will significantly increase the throughput capabilit ies of their current machine and will also renew the warranty. Any company that believes that it can meet these requirements is invited to submit written notification to the Contract Specialist within 15 calendar days from the date of the publication of this notice. Supporting evidence must be furnished in sufficie nt detail to demonstrate the companys ability to meet the requirement. Information may be sent by email to the Contract Specialist at: john.fitzsimmons@amedd.army.mil . This notice of intent is not a request for competitive quotes. However, responses r eceived from responsible businesses prior to close of business on 26 Janauary 2007 will be evaluated. If no responses are received, USAMRAA will proceed with the sole source order. See numbered Note 22. 1. Contracting Activity: The contracting activity responsible for this action is the US Army Medical Research Acquisition Activity (USAMRAA), Fort Detrick, MD. 2. Description of Action: This approval is being requested for a new firm-fixed price contract using R&D funds. 3. Description of Supplies/Services: The required item is an upgrade from the genome sequencer 20 to the genome sequencer FLX upgrade. The instrument is used for the purpose of whole genome sequencing and the upgrade will significantly increase the throug hput capabilities of our current machine in addition to renewing the warranty. 4. Authority Cited: The statutory authority permitting other than full and open competition is 10U.S.C 2304 ? (1). The FAR citation is 6.302-1 and the FAR title is only one responsible source and no other supplies or services will satisfy agency requireme nts. 5. Reason for Authority Cited: The proposed vender for this action is Roche Diagnostics Corporation. Roche Diagnostics Corporation has the unique qualification for fulfilling the contract requirement because they are the only vendor distributing the upgra de cited above. No other vendor distributes this upgrade. By the authority of FAR 6.302-1, the required delivery schedule and the lead time involved is 31 January, 2007. 6. Efforts to Obtain Competition: Not applicable, NO effort will be made to solicit offers from as many potential sources as is practicable as there is only one source capable of performing the required services. No effective competition is anticipated. 7. Actions to Increase Competition: To date no actions to increase competition have been initiated. The genome sequencer FLX upgrade is an upgrade of a machine distributed by Roche Diagnostics Corporation and only available through Roche. 8. Market Research: Market research was conducted to find additional suppliers of the Roche Diagnostics Corporation genome sequencer FLX upgrade. The upgrade is specific to the machine being used and is distributed solely by Roche Diagnostics Corporation. The maintain consistency in the results and quality of the assays, only Roche Diagnostics Corporation can provide the genome sequencer FLX upgrade. Unless Roche installs the upgrade requested, there will be a termination of the warranty on the instrumen t. 9. Interested Sources: To date no other sources have written to express an interest. All sources other than Roche Diagnostics Corporation are rejected based upon the statutory authority permitting full and open competition (10 U.S.C. 2304?(1)) are rejecte d. This upon the FAR citation 6.302-1, only one responsible source and no other suppliers or services will satisf y agency requirements. 10. Other Facts a. Procurement history: Reasonable efforts to retrieve the following items from computer records, contract files, competition advocate office files or other sources are expected: (1) Contract numbers and dates of the last several awards. Not applicable (2) Competitive status of these actions. Not applicable (3) Authority previously used for less than full and open competition. Not applicable (4) If a justification was prepared to support the procurement made before this one, a summary of the contents of paragraph 7 of the justification for that procurement and an explanation of the results. Not applicable (5) If any prior award was accomplished by full and open competition, a detailed explanation of the changed circumstances. Not applicable (6) An explanation of any unusual patterns which may be revealed by the history, e.g., several consecutive, urgent buys. Not applicable (7) If a justification was prepared to support the procurement made before this one, briefly describe the circumstances justifying the buy and whether there have been any significant changes. Not applicable b. Acquisition data availability: A statement of work suitable for full and open competition can be developed for this procurement. It is not being completed because in order to maintain the merit and validity of scientific research, there is only one sou rce that can render the service requested. c. Unusual and compelling urgency: Not applicable d. Subcontracting competition: Not applicable
 
Place of Performance
Address: US Army Medical Research Acquisition Activity ATTN: MCMR-AAA, 820 Chandler Street Frederick MD
Zip Code: 21702-5014
Country: US
 
Record
SN01211231-W 20070114/070114190555 (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.